Rival drugmakers want to upend Pfizer’s dominance of the $7 billion worldwide market for pneumonia vaccines
Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles.
Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies developing shots that aim to win sales by protecting against even more strains of the pneumonia virus.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Squares Off With Merck, Other Drugmakers Over Lucrative Pneumonia VaccinesThe growing $7 billion market is currently dominated by Pfizer, and rivals’ interest in winning more of the business shows the pharmaceutical industry’s renewed focus on vaccines.
Read more »
Key earnings reports, market recap, economic reports reviewed and more: Monday's 5 things to knowTraders will be watching this week as Fox Corp. and News Corp. will release third-quarter earnings on Tuesday along with health company earnings including CVS Health and Pfizer.
Read more »
U.S. CDC director experiences COVID rebound after taking Pfizer's PaxlovidThe director of the U.S. Centers for Disease Control and Prevention (CDC), Rochelle Walensky, experienced a COVID-19 rebound after completing a course of Pfizer Inc's COVID-19 pill, the agency said on Monday.
Read more »
Pfizer Squares Off With Merck, Other Drugmakers Over Lucrative Pneumonia VaccinesThe growing $7 billion market is currently dominated by Pfizer, and rivals’ interest in winning more of the business shows the pharmaceutical industry’s renewed focus on vaccines.
Read more »
Actually, You Do Need a Stock PotRegular pots are fine if you don't mind small batches of sauce and boil overs.
Read more »
How Does Cellular Immunity Work?Vaccines or infections generate antibodies and cellular immunity, or B and T cells. Both are essential to the COVID vaccine and booster response. MedTwitter
Read more »